Emergent BioSolutions Inc (EBS)
9.27
-0.70
(-7.02%)
USD |
NYSE |
Nov 14, 16:00
8.91
-0.36
(-3.88%)
Pre-Market: 05:31
Emergent BioSolutions Cash and Short Term Investments (Quarterly): 149.90M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 149.90M |
| June 30, 2024 | 69.70M |
| March 31, 2024 | 78.50M |
| December 31, 2023 | 111.70M |
| September 30, 2023 | 87.80M |
| June 30, 2023 | 88.60M |
| March 31, 2023 | 430.20M |
| December 31, 2022 | 642.60M |
| September 30, 2022 | 240.90M |
| June 30, 2022 | 358.10M |
| March 31, 2022 | 435.80M |
| December 31, 2021 | 576.10M |
| September 30, 2021 | 403.80M |
| June 30, 2021 | 447.50M |
| March 31, 2021 | 547.80M |
| December 31, 2020 | 621.30M |
| September 30, 2020 | 415.00M |
| June 30, 2020 | 268.80M |
| March 31, 2020 | 181.50M |
| December 31, 2019 | 167.80M |
| September 30, 2019 | 139.20M |
| June 30, 2019 | 177.40M |
| March 31, 2019 | 137.20M |
| December 31, 2018 | 112.20M |
| September 30, 2018 | 339.36M |
| Date | Value |
|---|---|
| June 30, 2018 | 190.24M |
| March 31, 2018 | 163.61M |
| December 31, 2017 | 178.30M |
| September 30, 2017 | 340.99M |
| June 30, 2017 | 315.63M |
| March 31, 2017 | 270.17M |
| December 31, 2016 | 271.51M |
| September 30, 2016 | 298.93M |
| June 30, 2016 | 333.40M |
| March 31, 2016 | 341.02M |
| December 31, 2015 | 308.30M |
| September 30, 2015 | 308.72M |
| June 30, 2015 | 214.84M |
| March 31, 2015 | 216.52M |
| December 31, 2014 | 280.50M |
| September 30, 2014 | 242.25M |
| June 30, 2014 | 168.13M |
| March 31, 2014 | 160.22M |
| December 31, 2013 | 179.34M |
| September 30, 2013 | 172.56M |
| June 30, 2013 | 156.24M |
| March 31, 2013 | 130.24M |
| December 31, 2012 | 141.67M |
| September 30, 2012 | 197.90M |
| June 30, 2012 | 161.84M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
69.70M
Minimum
Jun 2024
642.60M
Maximum
Dec 2022
316.17M
Average
313.45M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Geovax Labs Inc | 1.562M |
| Tonix Pharmaceuticals Holding Corp | 4.156M |
| Abbott Laboratories | 7.788B |
| SIGA Technologies Inc | 99.27M |
| Chimerix Inc | 136.23M |